Susquehanna International Group, LLP 180 Life Sciences Corp. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$2.53 - $3.9 $101,705 - $156,780	-40,200 Reduced 50.63%	39,200 $102,000
Q4 2021 Feb 14, 2022	SELL	$3.27 - $6.38 $667,080 - $1.3 Million	-204,000 Reduced 71.98%	79,400 $310,000
Q3 2021 Nov 15, 2021	SELL	$5.11 - $10.81 $321,930 - $681,030	-63,000 Reduced 18.19%	283,400 $1.53 Million
Q2 2021 Aug 11, 2021	SELL	$6.7 - $11.98 $912,540 - $1.63 Million	-136,200 Reduced 28.22%	346,400 $3.46 Million
Q1 2021 May 17, 2021	BUY	$2.51 - $6.96 $1.21 Million - $3.36 Million	482,600 New	482,600 $3.17 Million

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $53.2M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.